A series of studies showed that loss of the Y chromosome helps cancer evade the body’s immune system response, resulting in more aggressive bladder cancer in men as they age. The findings, published in Nature, revealed that although Y chromosome loss diminishes immune response to fighting cancer in older men, the process may make bladder cancer more susceptible to treatment with immune
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have identified a strong association between the product of a gene expressed in most cancers, including the most common type of head and neck cancer, and elevated levels of white blood cells that produce antibodies within tumors.
Get latest articles and stories on Health at LatestLY. Immunotherapy has changed cancer treatment. Since the introduction of immunotherapy in 2011, the five-year survival rate in advanced melanoma, the most lethal form of skin cancer, has increased from less than 10% to more than 50%. Unfortunately, only approximately half of melanoma patients react to immunotherapy, and those who do not respond have a difficult future. Health News | Cancer Patients Who Do Not React to Immunotherapy Lack Crucial Immune Cells: Study.